1.Report Summary
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.2. Abbott Laboratories Inc.
3.2.1.Overview
3.2.2.Financial Analysis
3.2.3.SWOT Analysis
3.2.4.Recent Developments
3.3.F. Hoffmann-La Roche Ltd.
3.3.1.Overview
3.3.2.Financial Analysis
3.3.3.SWOT Analysis
3.3.4.Recent Developments
3.4. Merck and Co., Inc.
3.4.1.Overview
3.4.2.Financial Analysis
3.4.3.SWOT Analysis
3.4.4.Recent Developments
3.5.Novartis AG
3.5.1.Overview
3.5.2.Financial Analysis
3.5.3.SWOT Analysis
3.5.4.Recent Developments
3.6.Key Strategy Analysis
3.7.Impact of COVID-19 on Key Players
4.Market Segmentation
4.1.Global Cancer Biomarker Market by Biomarker Type
4.1.1.Genetic Biomarker
4.1.2.Protein Biomarker
4.2.Global Cancer Biomarker Market by Cancer Type
4.2.1.Lung Cancer
4.2.2.Prostate Cancer
4.2.3.Breast Cancer
4.2.4.Colorectal Cancer
4.2.5.Cervical Cancer
4.2.6.Other
4.3.Global Cancer Biomarker Market by Application
4.3.1.Drug Discovery and development
4.3.2.Diagnosis
4.3.3.Risk Assessment
4.3.4.Prognostics
4.4.Global Cancer Biomarker Market by Profiling Technology
4.4.1.Omnic Technology
4.4.2.Immunoassays
4.4.3.Cytogenetics
4.4.4.Bioinformatics
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Abcodia Ltd.
6.2.Agendia N.V.
6.3.Agilent Technologies, Inc.
6.4.Astellas Pharma Inc.,
6.5.Becton, Dickson, and Co.
6.6.Biodesix, Inc.
6.7.BioMérieux S.A.
6.8.Bio-Rad Laboratories, Inc.
6.9.Danaher Corp.
6.10.Diazyme Laboratories Inc.
6.11.Hologic, Inc.
6.12.Illumina, Inc.
6.13.Myriad Genetics, Inc.
6.14.NeoGenomics, Inc.
6.15.Pfizer Inc.
6.16.QIAGEN GmbH
6.17.Thermo Fisher Scientific Inc.
1.GLOBAL CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2021-2028 ($ MILLION)
2.GLOBAL GENETIC CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL PROTEIN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028 ($ MILLION)
5.GLOBAL LUNG CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL PROSTATE CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL BREAST CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL COLORECTAL CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9.GLOBAL CERVICAL CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10.GLOBAL CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11.GLOBAL CANCER BIOMARKER FOR DRUG DISCOVERY AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBAL CANCER BIOMARKER FOR DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13.GLOBAL CANCER BIOMARKER FOR RISK ASSESSMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14.GLOBAL CANCER BIOMARKER FOR PROGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15.GLOBAL CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY PROFILING TECHNOLOGY, 2021-2028 ($ MILLION)
16.GLOBAL OMICS TECHNOLOGY IN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17.GLOBAL IMMUNOASSAYS IN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18.GLOBAL CYTOGENETICS IN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
19.GLOBAL BIOINFORMATICS IN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20.GLOBAL CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
21.NORTH AMERICAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22.NORTH AMERICAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2021-2028 ($ MILLION)
23.NORTH AMERICAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028 ($ MILLION)
24.NORTH AMERICAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25.NORTH AMERICAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY PROFILING TECHNOLOGY, 2021-2028 ($ MILLION)
26.EUROPEAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27.EUROPEAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2021-2028 ($ MILLION)
28.EUROPEAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028 ($ MILLION)
29.EUROPEAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
30.EUROPEAN CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY PROFILING TECHNOLOGY, 2021-2028 ($ MILLION)
31.ASIA-PACIFIC CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
32.ASIA-PACIFIC CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2021-2028 ($ MILLION)
33.ASIA-PACIFIC CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028 ($ MILLION)
34.ASIA-PACIFIC CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
35.ASIA-PACIFIC CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY PROFILING TECHNOLOGY, 2021-2028 ($ MILLION)
36.REST OF THE WORLD CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
37.REST OF THE WORLD CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2021-2028 ($ MILLION)
38.REST OF THE WORLD CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028 ($ MILLION)
39.REST OF THE WORLD CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
40.REST OF THE WORLD CANCER BIOMARKER MARKET RESEARCH AND ANALYSIS BY PROFILING TECHNOLOGY, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL CANCER BIOMARKER MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL CANCER BIOMARKER MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL CANCER BIOMARKER MARKET, 2022-2028 (%)
4.GLOBAL CANCER BIOMARKER MARKET SHARE BY BIOMARKER TYPE, 2021 VS 2028 (%)
5.GLOBAL GENETIC CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL PROTEIN CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL CANCER BIOMARKER MARKET SHARE BY CANCER TYPE, 2021 VS 2028 (%)
8.GLOBAL LUNG CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL PROSTATE CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL BREAST CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL COLORECTAL CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12.GLOBAL CERVICAL CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13.GLOBAL OTHER CANCER BIOMARKER BY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL CANCER BIOMARKER MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
15.GLOBAL CANCER BIOMARKER FOR DRUG DISCOVERY AND DEVELOPMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16.GLOBAL CANCER BIOMARKER FOR DIAGNOSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17.GLOBAL CANCER BIOMARKER FOR RISK ASSESSMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18.GLOBAL CANCER BIOMARKER FOR PROGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19.GLOBAL CANCER BIOMARKER MARKET SHARE BY PROFILING TECHNOLOGY, 2021 VS 2028 (%)
20.GLOBAL OMICS TECHNOLOGY IN CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21.GLOBAL IMMUNOASSAYS IN CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
22.GLOBAL CYTOGENETICS IN CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
23.GLOBAL BIOINFORMATICS IN CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
24.GLOBAL CANCER BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
25.US CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
26.CANADA CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
27.UK CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
28.FRANCE CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
29.GERMANY CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
30.ITALY CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
31.SPAIN CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
32.REST OF EUROPE CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
33.INDIA CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
34.CHINA CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
35.JAPAN CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
36.SOUTH KOREA CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
37.REST OF ASIA-PACIFIC CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
38.REST OF THE WORLD CANCER BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)